2255 - Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- or DTG-Based 3-Drug Regimens

Saturday, October 22, 2022

12:15 PM – 12:45 PM US ET

Location: Hall BC - Arena 2

All relevant financial disclosures have been mitigated.

Rapid Fire Presenter(s)

Gerald Pierone, Jr., MD (he/him/his)

Medical Director
Whole Family Health Center
Vero Beach, Florida, United States

Disclosure: Disclosure(s): Gilead: Grant/Research Support (); GSK-VIIV: Grant/Research Support ()

Co-Author(s)

Jennifer S. Fusco, BS

Chief Science Officer
Epividian, Inc.
Durham, North Carolina, United States

Disclosure: Disclosure(s): AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co.: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()
LB

Laurence Brunet, PhD

Director of Epidemiology
Epividian, Inc.
Durham, North Carolina, United States

Disclosure: Disclosure(s): AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()
Vani Vannappagari, MBBS, MPH, PhD

Global Head, Epidemiology & Real World Evidence
ViiV Healthcare
Research Triangle Park, North Carolina, United States

Disclosure: Disclosure(s): ViiV Healthcare: I am full time employee of ViiV Healthcare and receive GlaxoSmithKline stock as part of my compensation package (), Stocks/Bonds ()
SS

Supriya Sarkar, PhD, MPH

Director, Epidemiology and Real World Evidence
ViiV Healthcare
Baltimore, Maryland, United States

Disclosure: Disclosure(s): ViiV Healthcare: Salary (), Stocks/Bonds ()
CH

Cassidy Henegar, PhD, MSPH

Director
ViiV Healthcare
Chapel Hill, North Carolina, United States

Disclosure: Disclosure(s): GlaxoSmithKline: Stocks/Bonds (); ViiV Healthcare: full-time employee ()
Jv

Jean A. van Wyk, MB,ChB; MFPM

Global Medical Lead, VP
ViiV Healthcare Limited
Brentford, England, United Kingdom

Disclosure: Disclosure(s): ViiV Healthcare Limited: I am an employee of ViiV Healthcare (), Stocks/Bonds ()
AZ

Andrew Zolopa, MD

Head of North America Medical Affairs
ViiV Healthcare
Portola Valley, California, United States

Disclosure: Disclosure(s): ViiV Healthcare: full time employee (), Stocks/Bonds ()
GF

Gregory P. Fusco, MD, MPH

Chief Executive Officer & Chief Medical Officer
Epividian, Inc.
Durham, North Carolina, United States

Disclosure: Disclosure(s): AIDS Healthcare Foundation: Client of employer (); EMD: Grant/Research Support (); Gilead Sciences: Client of employer (); Janssen: Client of employer (); Merck & Co.: Client of employer (); Theratechnologies: Client of employer (); ViiV Healthcare: Client of employer ()

Disclosure(s):

Gerald Pierone, MD, Jr.: Gilead: Grant/Research Support (); GSK-VIIV: Grant/Research Support ()

Jennifer S. Fusco, BS: AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co.: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()

Laurence Brunet, PhD: AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()

Vani Vannappagari, MBBS, MPH, PhD: ViiV Healthcare: I am full time employee of ViiV Healthcare and receive GlaxoSmithKline stock as part of my compensation package (), Stocks/Bonds ()

Supriya Sarkar, PhD, MPH: ViiV Healthcare: Salary (), Stocks/Bonds ()

Cassidy Henegar, PhD, MSPH: GlaxoSmithKline: Stocks/Bonds (); ViiV Healthcare: full-time employee ()

Jean A. van Wyk, MB,ChB; MFPM: ViiV Healthcare Limited: I am an employee of ViiV Healthcare (), Stocks/Bonds ()

Andrew Zolopa, MD: ViiV Healthcare: full time employee (), Stocks/Bonds ()

Gregory P. Fusco, MD, MPH: AIDS Healthcare Foundation: Client of employer (); EMD: Grant/Research Support (); Gilead Sciences: Client of employer (); Janssen: Client of employer (); Merck & Co.: Client of employer (); Theratechnologies: Client of employer (); ViiV Healthcare: Client of employer ()